Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics

Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of...

Full description

Saved in:
Bibliographic Details
Published inNeurotherapeutics Vol. 14; no. 4; pp. 945 - 951
Main Authors Amezcua, Lilyana, Nelson, Flavia
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.10.2017
Springer US
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1878-7479
1933-7213
1878-7479
DOI10.1007/s13311-017-0560-9

Cover

Abstract Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.
AbstractList Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.
Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.
Author Nelson, Flavia
Amezcua, Lilyana
Author_xml – sequence: 1
  givenname: Lilyana
  orcidid: 0000-0003-1542-7819
  surname: Amezcua
  fullname: Amezcua, Lilyana
  email: lamezcua@usc.edu
  organization: Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
– sequence: 2
  givenname: Flavia
  surname: Nelson
  fullname: Nelson, Flavia
  organization: Department of Neurology, McGovern Medical School, University of Texas, Houston, TX, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28779373$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhS1URH_gAdigSGy6SbHjODfeIKFRC0hFIGjXlse-6bh47MFOKvXt8ZC2GrqYla_k8x0d3-NjchBiQELeMnrGKIUPmXHOWE0Z1FR0tJYvyBHroa-hBXmwMx-S45xvKRWcy_4VOWx6AMmBH5Hr83HljPbVIobsLCY9ujJVcah-lBHDWF9MwaKtfmJGncyqGmKqvk1-dBuP1S_jMcXscnW1KvAGp9GZ_Jq8HLTP-ObhPCHXF-dXiy_15ffPXxefLmsjGjrWXHbGDgxtu-wtW2ox6K7RogXbC9Na2eHAtC1hGylpazhD3bEOkFnQvYaBn5CPs-9mWq7RmhI3aa82ya11uldRO_X_TXArdRPvlICmgU4Ug9MHgxT_TJhHtXbZoPc6YJyyYrLpuh5a1hbp-2fS2zilUJ5XVNAKToFCUb3bTfQU5XHjRQCzwJS15YSDMm78t_QS0HnFqNp2q-ZuVelWbbtVspDsGflovo9pZiYXbbjBtBN6DyRnCEt1d65Axruw_SW_8V7Z6PawfwHx4smj
CitedBy_id crossref_primary_10_1007_s13311_017_0576_1
crossref_primary_10_1016_j_intimp_2018_05_020
crossref_primary_10_33920_med_03_2010_06
crossref_primary_10_18699_SSMJ20210101
crossref_primary_10_1016_j_jemep_2020_100465
crossref_primary_10_1016_j_preteyeres_2019_100779
Cites_doi 10.1016/j.jns.2011.08.036
10.1016/S1474-4422(09)70017-1
10.1212/WNL.0000000000001608
10.1001/jamaneurol.2014.3780
10.1111/jlme.12169
10.1001/jama.283.20.2701
10.1177/1352458510394941
10.1016/S1474-4422(08)70111-X
10.1371/journal.pone.0135997
10.1136/medethics-2015-102663
10.1136/jech.2008.084939
10.1007/s11606-017-4012-3
10.1016/j.stemcr.2014.06.012
10.1371/journal.pmed.1001402
10.1212/CPJ.0000000000000112
10.1177/1756285612437360
10.1016/j.jcyt.2016.08.007
10.1191/1352458505ms1215oa
10.1016/S1474-4422(11)70305-2
10.1212/WNL.0000000000001329
10.1038/nbt.2692
10.1007/BF02743135
10.1007/s00431-017-2852-9
10.1016/j.msard.2016.04.001
10.1056/NEJMp1700736
10.1016/j.stem.2015.07.016
10.3109/07853890.2015.1051579
10.1212/CPJ.0000000000000016
10.1056/NEJM198601303140510
10.1002/ana.22006
10.4103/2229-3485.71856
ContentType Journal Article
Copyright 2017 The American Society for Experimental NeuroTherapeutics, Inc.
The American Society for Experimental NeuroTherapeutics, Inc. 2017
Neurotherapeutics is a copyright of Springer, (2017). All Rights Reserved.
Copyright_xml – notice: 2017 The American Society for Experimental NeuroTherapeutics, Inc.
– notice: The American Society for Experimental NeuroTherapeutics, Inc. 2017
– notice: Neurotherapeutics is a copyright of Springer, (2017). All Rights Reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TK
7X7
7XB
88E
88G
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
KB0
M0S
M1P
M2M
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1007/s13311-017-0560-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials Local Electronic Collection Information
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
Proquest Medical Database
Psychology Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
ProQuest One Psychology

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1878-7479
EndPage 951
ExternalDocumentID PMC5722765
28779373
10_1007_s13311_017_0560_9
S1878747923014150
Genre Journal Article
Review
GroupedDBID ---
--K
.1-
.FO
06D
0R~
0VY
123
1B1
203
29~
2JY
2KG
2KM
2VQ
30V
4.4
406
408
40E
53G
5VS
67N
71M
7RV
7X7
88E
8AO
8FI
8FJ
8UJ
96X
AAAVM
AABHQ
AAEDT
AAFWJ
AAHNG
AAIAL
AAJBT
AAJKR
AAKDD
AALRI
AANXM
AANZL
AAQFI
AARHV
AARTL
AATVU
AAUYE
AAWCG
AAXUO
AAYIU
AAYQN
AAYTO
AAYWO
AAYZH
AAZMS
ABDZT
ABECU
ABFSG
ABFTV
ABIPD
ABIVO
ABJOX
ABKCH
ABMQK
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABUWG
ABWVN
ABXPI
ACGFS
ACHSB
ACKNC
ACMDZ
ACMLO
ACOKC
ACPRK
ACRPL
ACSTC
ACVFH
ADBBV
ADCNI
ADHIR
ADJJI
ADKNI
ADKPE
ADMUD
ADNMO
ADRFC
ADTPH
ADURQ
ADVLN
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEJRE
AEKER
AENEX
AEOHA
AEPYU
AESKC
AETCA
AEUPX
AEVLU
AEXYK
AEZWR
AFBBN
AFHIU
AFJKZ
AFKRA
AFLOW
AFPKN
AFPUW
AFQWF
AFRHN
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGII
AIIXL
AILAN
AITGF
AITUG
AIXLP
AJBLW
AJRNO
AJUYK
AJZVZ
AKBMS
AKMHD
AKRWK
AKYEP
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMRAJ
AMXSW
AMYLF
ANMIH
AOCGG
AOIJS
APXCP
ASPBG
ATHPR
AVWKF
AXYYD
AYFIA
AZFZN
AZQEC
BENPR
BGNMA
BKEYQ
BMSDO
BPHCQ
BVXVI
CCPQU
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
DWQXO
DX2
EBS
EIOEI
EJD
EN4
EO8
EO9
EP2
EP3
ESBYG
EX3
F5P
FDB
FEDTE
FERAY
FFXSO
FINBP
FNLPD
FNPLU
FRRFC
FSGXE
FYUFA
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ7
GROUPED_DOAJ
H13
HF~
HMCUK
HMJXF
HRMNR
HVGLF
HYE
HZ~
I0C
IHE
IKXTQ
IMOTQ
ITM
IWAJR
J-C
JBSCW
JZLTJ
KOV
LLZTM
M1P
M2M
M41
M4Y
MO0
NAPCQ
NPVJJ
NQ-
NQJWS
NU0
O9-
O93
O9I
O9J
OK1
OZT
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PSYQQ
PUEGO
R9I
RLLFE
ROL
RPM
RPZ
RSV
S1Z
S27
S3A
S3B
SBL
SDG
SHX
SISQX
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
T13
TSG
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VFIZW
W48
WK8
WOW
Z5R
ZMTXR
ZOVNA
~A9
-56
-5G
-BR
-EM
-~C
04C
2JN
3V.
ABAKF
ABULA
ACZOJ
ADINQ
AEFQL
AFCTW
ALIPV
EIHBH
GQ6
RIG
SV3
Z7U
Z83
Z87
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
EBLON
5PM
ID FETCH-LOGICAL-c520t-396cdf1ed4b8d1ba5fa62a547d85c4d96ef1ad28729904c31ea6167e1d7a8a7f3
IEDL.DBID AGYKE
ISSN 1878-7479
1933-7213
IngestDate Thu Aug 21 18:09:44 EDT 2025
Fri Sep 05 04:57:07 EDT 2025
Wed Aug 13 10:52:55 EDT 2025
Thu Apr 03 07:04:02 EDT 2025
Tue Jul 01 02:14:21 EDT 2025
Thu Apr 24 22:56:28 EDT 2025
Fri Feb 21 02:34:39 EST 2025
Tue Aug 26 20:09:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Ethics
Multiple sclerosis
Patient-funded research
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c520t-396cdf1ed4b8d1ba5fa62a547d85c4d96ef1ad28729904c31ea6167e1d7a8a7f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Literature Review-3
ObjectType-Review-3
content type line 23
ORCID 0000-0003-1542-7819
OpenAccessLink https://www.clinicalkey.com/#!/content/1-s2.0-S1878747923014150
PMID 28779373
PQID 1974530707
PQPubID 1476362
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5722765
proquest_miscellaneous_1926687414
proquest_journals_1974530707
pubmed_primary_28779373
crossref_citationtrail_10_1007_s13311_017_0560_9
crossref_primary_10_1007_s13311_017_0560_9
springer_journals_10_1007_s13311_017_0560_9
elsevier_clinicalkey_doi_10_1007_s13311_017_0560_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-10-01
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationSubtitle The Journal of the American Society for Experimental NeuroTherapeutics
PublicationTitle Neurotherapeutics
PublicationTitleAbbrev Neurotherapeutics
PublicationTitleAlternate Neurotherapeutics
PublicationYear 2017
Publisher Elsevier Inc
Springer US
Springer Nature B.V
Publisher_xml – name: Elsevier Inc
– name: Springer US
– name: Springer Nature B.V
References Tenembaum (bib35) 2012; 5
Klein, Solomon, Corboy, Bernat (bib24) 2016; 8
Cree, Kornyeyeva, Goodin (bib8) 2010; 68
Morgan-Followell, Nicholas, Weisleder (bib36) 2014; 20
Mancardi, Sormani, Gualandi (bib13) 2015; 84
Burt, Loh, Cohen (bib17) 2009; 8
Schwenzer (bib31) 2008; 53
Simonson, Domogatskaya, Volchkov, Rodin (bib19) 2015; 47
Spelsberg, Martiny, Schoenhoefer (bib27) 2009; 63
Freedman, Cohen (bib18) 2011; 17
Vayena, Tasioulas (bib7) 2013; 10
Perry, Cox, Cox (bib9) 2014; 42
Harris, Yan, Vyshkina, Sahabi, Liu, Sadiq (bib21) 2012; 313
Harris, Vyshkina, Sadiq (bib15) 2016; 18
Menikoff, Kaneshiro, Pritchard (bib32) 2017; 376
Connick, Kolappan, Crawley (bib12) 2012; 11
Sakpal (bib11) 2010; 1
Kastner, Behre, Lutz (bib28) 2015; 10
Douvaras, Wang, Zimmer (bib16) 2014; 3
Giannuzzi, Devlieger, Margari (bib4) 2017; 176
Pham-Kanter, Mello, Lehmann, Campbell, Carpenter (bib25) 2017; 32
Khan, Williams, Amezcua, Javed, Larsen, Smrtka (bib33) 2015; 5
Vayena, Tasioulas (bib3) 2013; 31
Shabas, Heffner (bib34) 2005; 11
Vayena, Brownsword, Edwards (bib2) 2016; 42
Corboy (bib26) 2014; 4
bib23
Ramsay, Rowan, Pryor (bib30) 2004; 62
Hartung, Bourdette, Ahmed, Whitham (bib1) 2015; 84
Emanuel, Wendler, Grady (bib10) 2000; 283
Weinfurt, Friedman, Allsbrook, Dinan, Hall, Sugarman (bib20) 2006; 21
Wenner, Kimmelman, London (bib6) 2015; 17
Lind (bib5) 1986; 314
Nash, Hutton, Racke (bib14) 2015; 72
Gehring, Sitskoorn, Aaronson, Taphoorn (bib29) 2008; 7
Emanuel, Wendler, Grady (CR10) 2000; 283
Perry, Cox, Cox (CR9) 2014; 42
Mancardi, Sormani, Gualandi (CR13) 2015; 84
Connick, Kolappan, Crawley (CR12) 2012; 11
Douvaras, Wang, Zimmer (CR16) 2014; 3
Kastner, Behre, Lutz (CR28) 2015; 10
Wenner, Kimmelman, London (CR6) 2015; 17
Schwenzer (CR31) 2008; 53
Harris, Yan, Vyshkina, Sahabi, Liu, Sadiq (CR21) 2012; 313
Vayena, Tasioulas (CR7) 2013; 10
CR30
Khan, Williams, Amezcua, Javed, Larsen, Smrtka (CR33) 2015; 5
Freedman, Cohen (CR18) 2011; 17
Sakpal (CR11) 2010; 1
Simonson, Domogatskaya, Volchkov, Rodin (CR19) 2015; 47
Giannuzzi, Devlieger, Margari (CR4) 2017; 176
Harris, Vyshkina, Sadiq (CR15) 2016; 18
Vayena, Brownsword, Edwards (CR2) 2016; 42
Shabas, Heffner (CR34) 2005; 11
Lind (CR5) 1986; 314
Nash, Hutton, Racke (CR14) 2015; 72
Weinfurt, Friedman, Allsbrook, Dinan, Hall, Sugarman (CR20) 2006; 21
Spelsberg, Martiny, Schoenhoefer (CR27) 2009; 63
Corboy (CR26) 2014; 4
CR23
Menikoff, Kaneshiro, Pritchard (CR32) 2017; 376
CR22
Burt, Loh, Cohen (CR17) 2009; 8
Pham-Kanter, Mello, Lehmann, Campbell, Carpenter (CR25) 2017; 32
Cree, Kornyeyeva, Goodin (CR8) 2010; 68
Morgan-Followell, Nicholas, Weisleder (CR36) 2014; 20
Klein, Solomon, Corboy, Bernat (CR24) 2016; 8
Gehring, Sitskoorn, Aaronson, Taphoorn (CR29) 2008; 7
Vayena, Tasioulas (CR3) 2013; 31
Tenembaum (CR35) 2012; 5
Hartung, Bourdette, Ahmed, Whitham (CR1) 2015; 84
Corboy (10.1007/s13311-017-0560-9_bib26) 2014; 4
Nash (10.1007/s13311-017-0560-9_bib14) 2015; 72
Hartung (10.1007/s13311-017-0560-9_bib1) 2015; 84
Vayena (10.1007/s13311-017-0560-9_bib7) 2013; 10
Weinfurt (10.1007/s13311-017-0560-9_bib20) 2006; 21
Cree (10.1007/s13311-017-0560-9_bib8) 2010; 68
Schwenzer (10.1007/s13311-017-0560-9_bib31) 2008; 53
Vayena (10.1007/s13311-017-0560-9_bib3) 2013; 31
Perry (10.1007/s13311-017-0560-9_bib9) 2014; 42
Emanuel (10.1007/s13311-017-0560-9_bib10) 2000; 283
Harris (10.1007/s13311-017-0560-9_bib21) 2012; 313
Simonson (10.1007/s13311-017-0560-9_bib19) 2015; 47
Klein (10.1007/s13311-017-0560-9_bib24) 2016; 8
Pham-Kanter (10.1007/s13311-017-0560-9_bib25) 2017; 32
Wenner (10.1007/s13311-017-0560-9_bib6) 2015; 17
10.1007/s13311-017-0560-9_bib22
Connick (10.1007/s13311-017-0560-9_bib12) 2012; 11
Gehring (10.1007/s13311-017-0560-9_bib29) 2008; 7
10.1007/s13311-017-0560-9_bib23
Douvaras (10.1007/s13311-017-0560-9_bib16) 2014; 3
Menikoff (10.1007/s13311-017-0560-9_bib32) 2017; 376
Vayena (10.1007/s13311-017-0560-9_bib2) 2016; 42
Morgan-Followell (10.1007/s13311-017-0560-9_bib36) 2014; 20
Ramsay (10.1007/s13311-017-0560-9_bib30) 2004; 62
Giannuzzi (10.1007/s13311-017-0560-9_bib4) 2017; 176
Kastner (10.1007/s13311-017-0560-9_bib28) 2015; 10
Mancardi (10.1007/s13311-017-0560-9_bib13) 2015; 84
Freedman (10.1007/s13311-017-0560-9_bib18) 2011; 17
Sakpal (10.1007/s13311-017-0560-9_bib11) 2010; 1
Lind (10.1007/s13311-017-0560-9_bib5) 1986; 314
Burt (10.1007/s13311-017-0560-9_bib17) 2009; 8
Harris (10.1007/s13311-017-0560-9_bib15) 2016; 18
Tenembaum (10.1007/s13311-017-0560-9_bib35) 2012; 5
Shabas (10.1007/s13311-017-0560-9_bib34) 2005; 11
Khan (10.1007/s13311-017-0560-9_bib33) 2015; 5
Spelsberg (10.1007/s13311-017-0560-9_bib27) 2009; 63
References_xml – volume: 42
  start-page: 475
  year: 2014
  end-page: 491
  ident: bib9
  article-title: Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies
  publication-title: J Law Med Ethics
– volume: 8
  start-page: 4
  year: 2016
  end-page: 8
  ident: bib24
  article-title: Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust
  publication-title: Mult Scler Relat Disord
– volume: 68
  start-page: 145
  year: 2010
  end-page: 150
  ident: bib8
  article-title: Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis
  publication-title: Ann Neurol
– volume: 314
  start-page: 312
  year: 1986
  end-page: 315
  ident: bib5
  article-title: Fee-for-service research
  publication-title: N Engl J Med
– volume: 17
  start-page: 135
  year: 2015
  end-page: 137
  ident: bib6
  article-title: Patient-funded trials: Opportunity or liability?
  publication-title: Cell Stem Cell
– volume: 42
  start-page: 216
  year: 2016
  end-page: 219
  ident: bib2
  article-title: Research led by participants: a new social contract for a new kind of research
  publication-title: J Med Ethics
– volume: 63
  start-page: 603
  year: 2009
  end-page: 605
  ident: bib27
  article-title: Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?
  publication-title: J Epidemiol Commun Health
– volume: 53
  start-page: 1342
  year: 2008
  end-page: 1349
  ident: bib31
  article-title: Protecting vulnerable subjects in clinical research: children, pregnant women, prisoners, and employees
  publication-title: Respir Care
– volume: 72
  start-page: 159
  year: 2015
  end-page: 169
  ident: bib14
  article-title: High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report
  publication-title: JAMA Neurol
– volume: 376
  start-page: 613
  year: 2017
  end-page: 615
  ident: bib32
  article-title: The common rule, updated
  publication-title: N Engl J Med
– volume: 4
  start-page: 161
  year: 2014
  end-page: 163
  ident: bib26
  article-title: The relationship between physicians and Pharma: playing the devil's advocate
  publication-title: Neurol Clin Pract
– volume: 11
  start-page: 635
  year: 2005
  end-page: 640
  ident: bib34
  article-title: Multiple sclerosis management for low-income minorities
  publication-title: Mult Scler
– volume: 7
  start-page: 548
  year: 2008
  end-page: 560
  ident: bib29
  article-title: Interventions for cognitive deficits in adults with brain tumours
  publication-title: Lancet Neurol
– volume: 10
  start-page: e1001402
  year: 2013
  ident: bib7
  article-title: Adapting standards: ethical oversight of participant-led health research
  publication-title: PLOS Med
– volume: 176
  start-page: 395
  year: 2017
  end-page: 405
  ident: bib4
  article-title: The ethical framework for performing research with rare inherited neurometabolic disease patients
  publication-title: Eur J Pediatr
– volume: 18
  start-page: 1476
  year: 2016
  end-page: 1482
  ident: bib15
  article-title: Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis
  publication-title: Cytotherapy
– volume: 1
  start-page: 67
  year: 2010
  end-page: 69
  ident: bib11
  article-title: Sample size estimation in clinical trial
  publication-title: Perspect Clin Res
– volume: 20
  start-page: 177
  year: 2014
  end-page: 180
  ident: bib36
  article-title: Reproductive issues in women with multiple sclerosis: ethical considerations
  publication-title: Continuum (Minneap Minn)
– volume: 5
  start-page: 139
  year: 2012
  end-page: 146
  ident: bib35
  article-title: Ethical challenges in paediatric clinical trials in multiple sclerosis
  publication-title: Ther Adv Neurol Disord
– volume: 84
  start-page: 2185
  year: 2015
  end-page: 2192
  ident: bib1
  article-title: The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
  publication-title: Neurology
– volume: 31
  start-page: 786
  year: 2013
  end-page: 787
  ident: bib3
  article-title: The ethics of participant-led biomedical research
  publication-title: Nat Biotechnol
– volume: 8
  start-page: 244
  year: 2009
  end-page: 253
  ident: bib17
  article-title: Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
  publication-title: Lancet Neurol
– volume: 283
  start-page: 2701
  year: 2000
  end-page: 2711
  ident: bib10
  article-title: What makes clinical research ethical?
  publication-title: JAMA
– volume: 47
  start-page: 370
  year: 2015
  end-page: 380
  ident: bib19
  article-title: The safety of human pluripotent stem cells in clinical treatment
  publication-title: Ann Med
– volume: 10
  start-page: e0135997
  year: 2015
  ident: bib28
  article-title: Clinical research in vulnerable populations: variability and focus of institutional review boards' responses
  publication-title: PLOS ONE
– volume: 62
  start-page: S24
  year: 2004
  end-page: S29
  ident: bib30
  article-title: Special considerations in treating the elderly patient with epilepsy
  publication-title: Neurology
– volume: 5
  start-page: 132
  year: 2015
  end-page: 142
  ident: bib33
  article-title: Multiple sclerosis in US minority populations: clinical practice insights
  publication-title: Neurol Clin Pract
– volume: 21
  start-page: 901
  year: 2006
  end-page: 906
  ident: bib20
  article-title: Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure
  publication-title: J Gen Intern Med
– ident: bib23
– volume: 32
  start-page: 767
  year: 2017
  end-page: 774
  ident: bib25
  article-title: Public awareness of and contact with physicians who receive industry payments: a national survey
  publication-title: J Gen Intern Med
– volume: 313
  start-page: 167
  year: 2012
  end-page: 177
  ident: bib21
  article-title: Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis
  publication-title: J Neurol Sci
– volume: 3
  start-page: 250
  year: 2014
  end-page: 259
  ident: bib16
  article-title: Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells
  publication-title: Stem Cell Rep
– volume: 17
  start-page: 131
  year: 2011
  end-page: 132
  ident: bib18
  article-title: Meta-analysis of bone marrow transplantation treatment studies: mixing ‘apples and oranges’
  publication-title: Mult Scler
– volume: 11
  start-page: 150
  year: 2012
  end-page: 156
  ident: bib12
  article-title: Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
  publication-title: Lancet Neurol
– volume: 84
  start-page: 981
  year: 2015
  end-page: 988
  ident: bib13
  article-title: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
  publication-title: Neurology
– ident: CR22
– volume: 313
  start-page: 167
  year: 2012
  end-page: 177
  ident: CR21
  article-title: Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2011.08.036
– volume: 1
  start-page: 67
  year: 2010
  end-page: 69
  ident: CR11
  article-title: Sample size estimation in clinical trial
  publication-title: Perspect Clin Res
– volume: 8
  start-page: 244
  year: 2009
  end-page: 253
  ident: CR17
  article-title: Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(09)70017-1
– volume: 84
  start-page: 2185
  year: 2015
  end-page: 2192
  ident: CR1
  article-title: The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000001608
– volume: 72
  start-page: 159
  year: 2015
  end-page: 169
  ident: CR14
  article-title: High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2014.3780
– ident: CR30
– volume: 42
  start-page: 475
  year: 2014
  end-page: 491
  ident: CR9
  article-title: Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies
  publication-title: J Law Med Ethics
  doi: 10.1111/jlme.12169
– volume: 283
  start-page: 2701
  year: 2000
  end-page: 2711
  ident: CR10
  article-title: What makes clinical research ethical?
  publication-title: JAMA
  doi: 10.1001/jama.283.20.2701
– volume: 17
  start-page: 131
  year: 2011
  end-page: 132
  ident: CR18
  article-title: Meta-analysis of bone marrow transplantation treatment studies: mixing 'apples and oranges'
  publication-title: Mult Scler
  doi: 10.1177/1352458510394941
– volume: 7
  start-page: 548
  year: 2008
  end-page: 560
  ident: CR29
  article-title: Interventions for cognitive deficits in adults with brain tumours
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(08)70111-X
– volume: 10
  start-page: e0135997
  year: 2015
  ident: CR28
  article-title: Clinical research in vulnerable populations: variability and focus of institutional review boards' responses
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0135997
– volume: 42
  start-page: 216
  year: 2016
  end-page: 219
  ident: CR2
  article-title: Research led by participants: a new social contract for a new kind of research
  publication-title: J Med Ethics
  doi: 10.1136/medethics-2015-102663
– volume: 63
  start-page: 603
  year: 2009
  end-page: 605
  ident: CR27
  article-title: Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?
  publication-title: J Epidemiol Commun Health
  doi: 10.1136/jech.2008.084939
– volume: 32
  start-page: 767
  year: 2017
  end-page: 774
  ident: CR25
  article-title: Public awareness of and contact with physicians who receive industry payments: a national survey
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-017-4012-3
– volume: 3
  start-page: 250
  year: 2014
  end-page: 259
  ident: CR16
  article-title: Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells
  publication-title: Stem Cell Rep
  doi: 10.1016/j.stemcr.2014.06.012
– volume: 10
  start-page: e1001402
  year: 2013
  ident: CR7
  article-title: Adapting standards: ethical oversight of participant-led health research
  publication-title: PLOS Med
  doi: 10.1371/journal.pmed.1001402
– volume: 5
  start-page: 132
  year: 2015
  end-page: 142
  ident: CR33
  article-title: Multiple sclerosis in US minority populations: clinical practice insights
  publication-title: Neurol Clin Pract
  doi: 10.1212/CPJ.0000000000000112
– volume: 5
  start-page: 139
  year: 2012
  end-page: 146
  ident: CR35
  article-title: Ethical challenges in paediatric clinical trials in multiple sclerosis
  publication-title: Ther Adv Neurol Disord
  doi: 10.1177/1756285612437360
– ident: CR23
– volume: 18
  start-page: 1476
  year: 2016
  end-page: 1482
  ident: CR15
  article-title: Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2016.08.007
– volume: 11
  start-page: 635
  year: 2005
  end-page: 640
  ident: CR34
  article-title: Multiple sclerosis management for low-income minorities
  publication-title: Mult Scler
  doi: 10.1191/1352458505ms1215oa
– volume: 11
  start-page: 150
  year: 2012
  end-page: 156
  ident: CR12
  article-title: Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(11)70305-2
– volume: 53
  start-page: 1342
  year: 2008
  end-page: 1349
  ident: CR31
  article-title: Protecting vulnerable subjects in clinical research: children, pregnant women, prisoners, and employees
  publication-title: Respir Care
– volume: 84
  start-page: 981
  year: 2015
  end-page: 988
  ident: CR13
  article-title: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000001329
– volume: 31
  start-page: 786
  year: 2013
  end-page: 787
  ident: CR3
  article-title: The ethics of participant-led biomedical research
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2692
– volume: 21
  start-page: 901
  year: 2006
  end-page: 906
  ident: CR20
  article-title: Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure
  publication-title: J Gen Intern Med
  doi: 10.1007/BF02743135
– volume: 176
  start-page: 395
  year: 2017
  end-page: 405
  ident: CR4
  article-title: The ethical framework for performing research with rare inherited neurometabolic disease patients
  publication-title: Eur J Pediatr
  doi: 10.1007/s00431-017-2852-9
– volume: 8
  start-page: 4
  year: 2016
  end-page: 8
  ident: CR24
  article-title: Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust
  publication-title: Mult Scler Relat Disord
  doi: 10.1016/j.msard.2016.04.001
– volume: 376
  start-page: 613
  year: 2017
  end-page: 615
  ident: CR32
  article-title: The common rule, updated
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp1700736
– volume: 20
  start-page: 177
  year: 2014
  end-page: 180
  ident: CR36
  article-title: Reproductive issues in women with multiple sclerosis: ethical considerations
  publication-title: Continuum (Minneap Minn)
– volume: 17
  start-page: 135
  year: 2015
  end-page: 137
  ident: CR6
  article-title: Patient-funded trials: Opportunity or liability?
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2015.07.016
– volume: 68
  start-page: 145
  year: 2010
  end-page: 150
  ident: CR8
  article-title: Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis
  publication-title: Ann Neurol
– volume: 47
  start-page: 370
  year: 2015
  end-page: 380
  ident: CR19
  article-title: The safety of human pluripotent stem cells in clinical treatment
  publication-title: Ann Med
  doi: 10.3109/07853890.2015.1051579
– volume: 4
  start-page: 161
  year: 2014
  end-page: 163
  ident: CR26
  article-title: The relationship between physicians and Pharma: playing the devil's advocate
  publication-title: Neurol Clin Pract
  doi: 10.1212/CPJ.0000000000000016
– volume: 314
  start-page: 312
  year: 1986
  end-page: 315
  ident: CR5
  article-title: Fee-for-service research
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198601303140510
– volume: 68
  start-page: 145
  year: 2010
  ident: 10.1007/s13311-017-0560-9_bib8
  article-title: Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis
  publication-title: Ann Neurol
  doi: 10.1002/ana.22006
– volume: 313
  start-page: 167
  year: 2012
  ident: 10.1007/s13311-017-0560-9_bib21
  article-title: Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis
  publication-title: J Neurol Sci
  doi: 10.1016/j.jns.2011.08.036
– volume: 20
  start-page: 177
  year: 2014
  ident: 10.1007/s13311-017-0560-9_bib36
  article-title: Reproductive issues in women with multiple sclerosis: ethical considerations
  publication-title: Continuum (Minneap Minn)
– volume: 11
  start-page: 150
  year: 2012
  ident: 10.1007/s13311-017-0560-9_bib12
  article-title: Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(11)70305-2
– volume: 376
  start-page: 613
  year: 2017
  ident: 10.1007/s13311-017-0560-9_bib32
  article-title: The common rule, updated
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp1700736
– volume: 42
  start-page: 216
  year: 2016
  ident: 10.1007/s13311-017-0560-9_bib2
  article-title: Research led by participants: a new social contract for a new kind of research
  publication-title: J Med Ethics
  doi: 10.1136/medethics-2015-102663
– volume: 47
  start-page: 370
  year: 2015
  ident: 10.1007/s13311-017-0560-9_bib19
  article-title: The safety of human pluripotent stem cells in clinical treatment
  publication-title: Ann Med
  doi: 10.3109/07853890.2015.1051579
– ident: 10.1007/s13311-017-0560-9_bib22
– volume: 314
  start-page: 312
  year: 1986
  ident: 10.1007/s13311-017-0560-9_bib5
  article-title: Fee-for-service research
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198601303140510
– volume: 1
  start-page: 67
  year: 2010
  ident: 10.1007/s13311-017-0560-9_bib11
  article-title: Sample size estimation in clinical trial
  publication-title: Perspect Clin Res
  doi: 10.4103/2229-3485.71856
– volume: 63
  start-page: 603
  year: 2009
  ident: 10.1007/s13311-017-0560-9_bib27
  article-title: Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?
  publication-title: J Epidemiol Commun Health
  doi: 10.1136/jech.2008.084939
– volume: 5
  start-page: 139
  year: 2012
  ident: 10.1007/s13311-017-0560-9_bib35
  article-title: Ethical challenges in paediatric clinical trials in multiple sclerosis
  publication-title: Ther Adv Neurol Disord
  doi: 10.1177/1756285612437360
– volume: 84
  start-page: 981
  year: 2015
  ident: 10.1007/s13311-017-0560-9_bib13
  article-title: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000001329
– volume: 32
  start-page: 767
  year: 2017
  ident: 10.1007/s13311-017-0560-9_bib25
  article-title: Public awareness of and contact with physicians who receive industry payments: a national survey
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-017-4012-3
– volume: 5
  start-page: 132
  year: 2015
  ident: 10.1007/s13311-017-0560-9_bib33
  article-title: Multiple sclerosis in US minority populations: clinical practice insights
  publication-title: Neurol Clin Pract
  doi: 10.1212/CPJ.0000000000000112
– volume: 8
  start-page: 4
  year: 2016
  ident: 10.1007/s13311-017-0560-9_bib24
  article-title: Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust
  publication-title: Mult Scler Relat Disord
  doi: 10.1016/j.msard.2016.04.001
– volume: 176
  start-page: 395
  year: 2017
  ident: 10.1007/s13311-017-0560-9_bib4
  article-title: The ethical framework for performing research with rare inherited neurometabolic disease patients
  publication-title: Eur J Pediatr
  doi: 10.1007/s00431-017-2852-9
– volume: 283
  start-page: 2701
  year: 2000
  ident: 10.1007/s13311-017-0560-9_bib10
  article-title: What makes clinical research ethical?
  publication-title: JAMA
  doi: 10.1001/jama.283.20.2701
– volume: 10
  start-page: e0135997
  year: 2015
  ident: 10.1007/s13311-017-0560-9_bib28
  article-title: Clinical research in vulnerable populations: variability and focus of institutional review boards' responses
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0135997
– volume: 42
  start-page: 475
  year: 2014
  ident: 10.1007/s13311-017-0560-9_bib9
  article-title: Trust and transparency: patient perceptions of physicians' financial relationships with pharmaceutical companies
  publication-title: J Law Med Ethics
  doi: 10.1111/jlme.12169
– volume: 3
  start-page: 250
  year: 2014
  ident: 10.1007/s13311-017-0560-9_bib16
  article-title: Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells
  publication-title: Stem Cell Rep
  doi: 10.1016/j.stemcr.2014.06.012
– volume: 11
  start-page: 635
  year: 2005
  ident: 10.1007/s13311-017-0560-9_bib34
  article-title: Multiple sclerosis management for low-income minorities
  publication-title: Mult Scler
  doi: 10.1191/1352458505ms1215oa
– volume: 18
  start-page: 1476
  year: 2016
  ident: 10.1007/s13311-017-0560-9_bib15
  article-title: Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis
  publication-title: Cytotherapy
  doi: 10.1016/j.jcyt.2016.08.007
– volume: 10
  start-page: e1001402
  year: 2013
  ident: 10.1007/s13311-017-0560-9_bib7
  article-title: Adapting standards: ethical oversight of participant-led health research
  publication-title: PLOS Med
  doi: 10.1371/journal.pmed.1001402
– ident: 10.1007/s13311-017-0560-9_bib23
– volume: 17
  start-page: 135
  year: 2015
  ident: 10.1007/s13311-017-0560-9_bib6
  article-title: Patient-funded trials: Opportunity or liability?
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2015.07.016
– volume: 31
  start-page: 786
  year: 2013
  ident: 10.1007/s13311-017-0560-9_bib3
  article-title: The ethics of participant-led biomedical research
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2692
– volume: 7
  start-page: 548
  year: 2008
  ident: 10.1007/s13311-017-0560-9_bib29
  article-title: Interventions for cognitive deficits in adults with brain tumours
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(08)70111-X
– volume: 72
  start-page: 159
  year: 2015
  ident: 10.1007/s13311-017-0560-9_bib14
  article-title: High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2014.3780
– volume: 17
  start-page: 131
  year: 2011
  ident: 10.1007/s13311-017-0560-9_bib18
  article-title: Meta-analysis of bone marrow transplantation treatment studies: mixing ‘apples and oranges’
  publication-title: Mult Scler
  doi: 10.1177/1352458510394941
– volume: 4
  start-page: 161
  year: 2014
  ident: 10.1007/s13311-017-0560-9_bib26
  article-title: The relationship between physicians and Pharma: playing the devil's advocate
  publication-title: Neurol Clin Pract
  doi: 10.1212/CPJ.0000000000000016
– volume: 62
  start-page: S24
  issue: 5 Suppl. 2
  year: 2004
  ident: 10.1007/s13311-017-0560-9_bib30
  article-title: Special considerations in treating the elderly patient with epilepsy
  publication-title: Neurology
– volume: 53
  start-page: 1342
  year: 2008
  ident: 10.1007/s13311-017-0560-9_bib31
  article-title: Protecting vulnerable subjects in clinical research: children, pregnant women, prisoners, and employees
  publication-title: Respir Care
– volume: 84
  start-page: 2185
  year: 2015
  ident: 10.1007/s13311-017-0560-9_bib1
  article-title: The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000001608
– volume: 21
  start-page: 901
  year: 2006
  ident: 10.1007/s13311-017-0560-9_bib20
  article-title: Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure
  publication-title: J Gen Intern Med
  doi: 10.1007/BF02743135
– volume: 8
  start-page: 244
  year: 2009
  ident: 10.1007/s13311-017-0560-9_bib17
  article-title: Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(09)70017-1
SSID ssj0053398
Score 2.2171607
SecondaryResourceType review_article
Snippet Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 945
SubjectTerms Biomedical and Life Sciences
Biomedicine
Ethics
Humans
Medical ethics
Multiple sclerosis
Multiple Sclerosis - economics
Multiple Sclerosis - therapy
Naltrexone
Neurobiology
Neurology
Neurosciences
Neurosurgery
Patient Participation
Patient-funded research
Review
Reviews
Stem cells
Translational Research, Biomedical - economics
Translational Research, Biomedical - ethics
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEB-0gvhSrJ9ba4ngkxLcbJLN5UlEPIpwItiDewvZfGBB9mrv-v93ks3uWUvvOdklmZkkv_kGeO8QdMcoBeUdqquC20A7pS0NIXrWadd4m0wDix_t2VJ8X8lVMbhtSljleCfmi9qvXbKRf2IIfGUSUPX58i9NXaOSd7W00HgIj3LpMpRntZoULkQyuRcuYhROUdPho1czp85xnjPKFEUIUFN937t0F3feDZ_8z4ean6b5UzgsmJJ8GYTgCB6E_hk8XhSv-XNY5qB2nDF25xysdGQdyc-hrCqdp1wyT8Y4PIJQlixKrCH5hX_FRV9syPkuW2vzApbzb-dfz2hpp0CdbOot5bp1PrLgRTdDPlgZbdtYKZSfSSe8bkNk1qMGlV4o4TgLtmWtCswrO7Mq8pdw0K_78BqI75gVVoZoAxOd1tZ1tbRN9LXV3ipVQT0S07hSazy1vPhjdlWSE_0N0t8k-htdwYfpk8uh0Ma-yc3IITNmkOKdZ_AZ2PfRychLUw7qxuzEqoJ30zAeseQ3sX1YX6c5iGJmCL1EBa8G1k9LRHKlCoO8AnVLKKYJqXz37ZH-4ncu4y1V06hWVvBxFJ9_lnXfJo73b-INPGmSTOdowxM42F5dh7eImrbdaT4aN6krFGQ
  priority: 102
  providerName: ProQuest
Title Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1878747923014150
https://link.springer.com/article/10.1007/s13311-017-0560-9
https://www.ncbi.nlm.nih.gov/pubmed/28779373
https://www.proquest.com/docview/1974530707
https://www.proquest.com/docview/1926687414
https://pubmed.ncbi.nlm.nih.gov/PMC5722765
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxEB7RVEJceD8WSrVInECu1q_1-hhQQkWUqiqJCKeVd22LCrRBJLnw6xnvrhPa0ko9-eCxZY_Hns-ehwHe1gi6vZeC8Aqvq4IbRyqlDXHOW1rpmlkTngamJ_nxXHxeyEUfx72K3u7RJNme1LtgN87bGDBFUGlnRO_BvqSFLgawP_z0bTKKBzACmPYLXIQmnOAFh0dj5v86uU4dXYWbV70mL5lOW400fgCzOJfOEeXH0WZdHdV_LqV5vOVkH8L9HqGmw06kHsEd1zyGu9PeBv8E5q2LPFLEvz67N7906dPTLkkrGYfINJtGr74UgXE67T0X0y_YK_LifJXOdrFfq6cwH49mH49J_zkDqSXL1oTrvLaeOiuqAlfVSG9yZqRQtpC1sDp3nhqL97Gg70TNqTM5zZWjVpnCKM-fwaBZNu4FpLaiRhjpvHFUVFqbusqkYd5mRlujVAJZXKOy7jOXhw80fpa7nMuBXSWyqwzsKnUC77ZNfnVpO24iZnHhyxiPiidoiUrlpkYHUUTKftuvSoq3MxlOURzzm201bthghTGNW24CDWKiAoGcSOB5J1HbISK7Qr5CnoC6IGtbgpAM_GJNc_69TQouFWMqlwm8jwL1z7Cum8TLW1G_gnssSGTryngAg_XvjXuNkGxdHcKeWqjDfiOGcnL2dYLlh9HJ6RnWztnwL4r6MrQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VVAIuiDfbFjASXEAWu36ssweEeDRKaRNVkEi9Ge_aFpXQpjSpUP8Uv5Hx7jqhVM2tZz9kz4zHnz0vgJcVgm7vpaC8xOeq4MbRUhWGOudtVhYVsyZ8DYzG-XAqvhzJow34E2Nhgltl1ImNorazKvyRv80Q-MogoOr9yS8aqkYF62osodGKxb47_41Ptvm7vc_I31eMDXYnn4a0qypAK8nSBeVFXlmfOSvKPi7HSG9yZqRQti8rYYvc-cxYfEgERS0qnjmTZ7lymVWmb5TnOO8N2BQhorUHmx93x4dfo-5H7NRU30VUxCm-rXi0ozbBepw3MWyKIuhIaXHVTXgZ6V522PzPattchoO7cKdDseRDK3b3YMPV9-HmqLPTP4Bp40aPPWI90PZfkMw8OWwTudJBiF6zJHr-EQTPZNR5N5JvOCsu-nhOJqv4sPlDmF4LqR9Br57V7gkQW2ZGGOm8cZkoi8JUZSoN8zY1hTVKJZBGYuqqy24eimz81Ku8zIH-GumvA_11kcDr5ZCTNrXHus4sckjHmFXUshovnnWDdiIvdaca5nolyAm8WDbjoQ6WGlO72Vnog7ipj2BPJPC4Zf1yiUiukNOQJ6AuCMWyQ0gYfrGlPv7RJA6XijGVywTeRPH5Z1lXbWJr_Saew63hZHSgD_bG-9twmwX5bnwdd6C3OD1zTxGzLcpn3UEh8P26z-Zf7RZTqQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB9qheKL-N3VqhH0RQndfG1uH0TEerTWKwV7cG8xu0mwIHvVuyL-a_51TnY3e9bSe-vzZkMymZn8JvMF8LJG0B2CklRUaK5KYT2tdGmp98Gxqqy5s_FpYHJU7E_lp5mabcCflAsTwyqTTmwVtZvX8Y18lyHwVZFB9W7owyKO98bvzn7Q2EEqelpTO42ORQ79719ovi3eHuzhWb_ifPzx5MM-7TsM0FrxfElFWdQuMO9kNcKlWRVswa2S2o1ULV1Z-MCsQ6MiKm1ZC-ZtwQrtmdN2ZHUQOO8NuKkFoiqUJT0bjD1EUW0fXsRHgqKVJZJHtU3bE6LNZtMU4UdOy6vuxMuY93Lo5n_-2_ZaHN-B2z2eJe87BrwLG765B1uT3mN_H6ZtQD2OSJ1BuxdCMg_kuCvpSscxj82RFANIEEaTSR_nSL7grLjo0wU5WWWKLR7A9FoI_RA2m3njt4G4illplQ_WM1mVpa2rXFkeXG5LZ7XOIE_ENHVf5zy22_huVhWaI_0N0t9E-psyg9fDL2ddkY91g3k6IZOyV1HfGryC1v20k87S9EpiYVYsncGL4TOKd_TZ2MbPz-MYRFAjhH0yg0fd0Q9LRHLF6oYiA32BKYYBsXT4xS_N6be2hLjSnOtCZfAmsc8_y7pqE4_Xb-I5bKFEms8HR4dP4BaP7N0GPe7A5vLnuX-K4G1ZPWulhMDX6xbLv-HTVnA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ethical+Considerations+of+Patient-Funded+Research+for+Multiple+Sclerosis+Therapeutics&rft.jtitle=Neurotherapeutics&rft.au=Amezcua%2C+Lilyana&rft.au=Nelson%2C+Flavia&rft.date=2017-10-01&rft.pub=Springer+US&rft.issn=1933-7213&rft.eissn=1878-7479&rft.volume=14&rft.issue=4&rft.spage=945&rft.epage=951&rft_id=info:doi/10.1007%2Fs13311-017-0560-9&rft.externalDocID=10_1007_s13311_017_0560_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1878-7479&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1878-7479&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1878-7479&client=summon